Akero Therapeutics (AKRO) Q2 2025 Earnings

May 12Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.16
-1.04
-0.93
-0.81

Details

Expected EPS
-0.959243
Actual EPS
-0.9
Surprise EPS
0.06
Surprise Percent
+6.18%

Description

⁨Akero Therapeutics⁩ (⁦AKRO⁩) has reported earnings of ⁦-0.9⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts